VIVEON HEALTH ACQUISITION CORP. Announces Adjournment of Special Meeting in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Until February 3, 2023.
NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) — Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU), a special purpose acquisition company (the “Company”), today announced that it held a special meeting of stockholders (the “Adjourned Special Meeting”) on January 20, 2023, to, among other things, approve the proposal by the Company to consummate its previously announced initial business combination with Suneva Medical, Inc. At the Adjourned Special Meeting stockholders voted to adjourn the meeting until February 3, 2023 at 12:00 p.m. Eastern Time.
Related news for (VHAQ)
- VIVEON HEALTHCARE ACQUISITION CORP. CONFIRMS COMMITMENT TO PROCEED WITH BUSINESS COMBINATION PROCESS
- VIVEON HEALTHCARE ACQUISITION CORP. CONFIRMS COMMITMENT TO PROCEED WITH BUSINESS COMBINATION PROCESS
- VIVEON HEALTHCARE ACQUISITION CORP CONFIRMS BUSINESS COMBINATION
- VIVEON HEALTHCARE ACQUISITION CORP CONFIRMS BUSINESS COMBINATION
- Viveon Health Acquisition Corp. Receives Commencement of Delisting Notice From the NYSE